EFFECTS OF TREATMENT WITH SIMVASTATIN AND PRAVASTATIN ON COGNITIVE FUNCTION IN PATIENTS WITH HYPERCHOLESTEROLEMIA

被引：41
|
作者：
CUTLER, N
SRAMEK, J
VEROFF, A
BLOCK, G
STAUFFER, L
LINES, C
机构：
[1] CALIF CLIN TRIALS,BEVERLY HILLS,CA 90211
[2] MERCK SHARP & DOHME LTD,RES LABS,BLUE BELL,PA 19422
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1995年 / 39卷 / 03期
关键词：
SIMVASTATIN; PRAVASTATIN; CHOLESTEROL; COGNITIVE FUNCTION;
D O I：
10.1111/j.1365-2125.1995.tb04458.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The effects of equi-efficacious doses of the cholesterol-lowering drugs simvastatin (20 mg day(-1)) and pravastatin (40 mg day(-1)) on tests of cognitive function were investigated in a double-blind, placebo-controlled, 2-period (4 weeks per period), incomplete block, crossover study of 36 patients (24 per treatment) with hypercholesterolaemia. After 4 weeks neither of the active treatments differed significantly from placebo on any cognitive measure.
引用
收藏
页码：333 / 336
页数：4
相关论文
共 50 条
  • [31] The evaluation of analgesic effects of simvastatin, pravastatin and atorvastatin in hot plate test
    Kesim, M.
    Kadioglu, M.
    Okuyan, M.
    Muci, E.
    Erkoseoglu, I.
    Kalyoncu, N. I.
    Yaris, E.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2012, 16 (06) : 789 - 796
  • [32] Pravastatin versus simvastatin in hyperlipidemic patients with type 2 diabetes mellitus
    Sugimoto, T
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1999, 60 (07): : 404 - 413
  • [33] Effects of Pravastatin on Serum Osteoprotegerin Levels in Patients With Hypercholesterolemia and Type 2 Diabetes
    Mori, Katsuhito
    Jono, Shuichi
    Emoto, Masanori
    Kawagishi, Takahiko
    Yasumoto, Hideo
    Konishi, Toshiaki
    Furumitsu, Yutaka
    Shioi, Atsushi
    Shoji, Tetsuo
    Inaba, Masaaki
    Nishizawa, Yoshiki
    ANGIOLOGY, 2010, 61 (01) : 86 - 91
  • [34] EFFECTS OF LONG-TERM TREATMENT WITH SIMVASTATIN ON PLASMA-LIPIDS AND LIPOPROTEINS IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA
    THIERY, J
    CREUTZFELDT, C
    CREUTZFELDT, W
    WALLI, AK
    SEIDEL, D
    KLINISCHE WOCHENSCHRIFT, 1990, 68 (16): : 814 - 822
  • [35] Effects of simvastatin on lipid levels and platelet activation in elderly patients with hypercholesterolemia
    Zhe Chen
    Journal of Geriatric Cardiology, 2007, (04) : 215 - 217
  • [36] Efficacy and safety of cerivastatin and pravastatin in the treatment of primary hypercholesterolemia
    Saunders, E
    Ferdinand, K
    Yellen, LG
    Tonkon, MJ
    Krug-Gourley, S
    Poland, M
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2000, 92 (07) : 319 - 326
  • [37] EFFICACY AND TOLERANCE OF SIMVASTATIN AND BEZAFIBRATE IN THE TREATMENT OF HYPERCHOLESTEROLEMIA
    BRUCKERT, E
    TRUFFERT, J
    DEGENNES, JL
    ANNALES DE MEDECINE INTERNE, 1991, 142 (07): : 505 - 510
  • [38] The safety of ezetimibe and simvastatin combination for the treatment of hypercholesterolemia
    Kei, Anastazia A.
    Filippatos, Theodosios D.
    Elisaf, Moses S.
    EXPERT OPINION ON DRUG SAFETY, 2016, 15 (04) : 559 - 569
  • [39] Double-Dose Pravastatin Versus Add-On Ezetimibe with Low-Dose Pravastatin - Effects on LDL Cholesterol, Cholesterol Absorption, and Cholesterol Synthesis in Japanese Patients with Hypercholesterolemia (PEAS study)
    Sasaki, Jun
    Otonari, Takatoshi
    Sawayama, Yasunori
    Hata, Shiro
    Oshima, Yoshimi
    Saikawa, Tetsunori
    Biro, Sadatoshi
    Kono, Suminori
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2012, 19 (05) : 485 - 493
  • [40] STRESS RESPONSES AFTER TREATMENT OF HYPERCHOLESTEROLEMIA WITH SIMVASTATIN
    NUGENT, AM
    NEELY, D
    YOUNG, I
    MCDOWELL, I
    OKANE, M
    BELL, N
    STANFORD, CF
    NICHOLLS, DP
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 36 (05) : 474 - 477
12345